Medicine - DER SPIEGEL

Zum Inhalt springen

Medicine

Alle Beiträge

Hopes Are High for the Technology that Is Leading Us Out of the Pandemic - Getty Images

The mRNA Revolution Hopes Are High for the Technology that Is Leading Us Out of the Pandemic

The vaccine success stories at BioNTech and Moderna may only be the beginning. Doctors and researchers want to use the revolutionary mRNA technology to fight the world's worst scourges: from cancer to dementia. By Jörg Blech und Claus Hecking

Patent Suspensions Threaten Germany's Booming Biotech Industry - Ramon Haindl

BioNTech, CureVac and Co. Patent Suspensions Threaten Germany's Booming Biotech Industry

With their next-generation mRNA vaccines, the German companies BioNTech and CureVac are at the forefront of pharmaceutical innovation. But U.S. President Joe Biden's plan to suspend patent protections is threatening that position. By Claus Hecking, Michael Sauga, Thomas Schulz und Gerald Traufetter

The Growing Debate over the Suspension of Vaccine Patents - Getty Images

A Dangerous Divide The Growing Debate over the Suspension of Vaccine Patents

The U.S. no longer want to enforce patent protection for COVID-19 vaccines, but critics argue that this will do little to improve the lack of access in the developing world. Some are calling for much more ambitious solutions. By Marian Blasberg und Marco Evers

How Feces and Other Bodily Fluids Can Help Track COVID Outbreaks - Ralf Hirschberger / picture alliance / dpa

"Sewage Doesn't Lie" How Feces and Other Bodily Fluids Can Help Track COVID Outbreaks

To detect coronavirus outbreaks early on, scientists are testing sewage plants and blood in addition to evaluating heart rates through fitness tracker data. Taken together, these systems could replace complicated track and trace efforts to contain the pandemic. By Hilmar Schmundt

Many Stay Sick After Recovering From Coronavirus - Nora Klein/ DER SPIEGEL

Strange Symptoms Many Stay Sick After Recovering From Coronavirus

One in 10 people infected with the coronavirus suffers from fatigue, muscle aches or neurological disorders for weeks after surviving an infection. What long-term damage does the virus do to the body? By Lisa Duhm und Veronika Hackenbroch

"When You Are Light-Skinned, You Earn More" - SIMON MAINA/ AFP

Skin Bleaching in Ghana "When You Are Light-Skinned, You Earn More"

A legacy of the colonial mindset, the market for skin-lightening products is booming in Ghana, with even some international conglomerates pushing bleaching creams. But the side effects can be deadly. By Anne Backhaus und Ella Okunmwendia in Accra, Ghana

A Look at the Treatments Currently Being Used against the Coronavirus - CARL DE SOUZA/ AFP

The COVID-19 Battle A Look at the Treatments Currently Being Used against the Coronavirus

In the fight against COVID-19, doctors and health workers are testing drugs and treatments whose efficacy has been proven against other illnesses. We take a look at the most prominent ones and the early findings. By Heike Le Ker

Germany Is Failing in its Efforts To Obtain Protective Gear - Xander Heinl/photothek.net/ imago images/photothek

A Crisis Unmasked Germany Is Failing in its Efforts To Obtain Protective Gear

The German government failed to obtain enough protective masks for the country. That's one of the reasons Germany has so far refused to require its citizen's to wear them in public. But those facial coverings could be critical in lifting restrictions on public life.

Are Hospitals Ready for the Coming Wave of Corona Cases? - FELIX VON DER OSTEN / DER SPIEGEL

The Battle Begins Are Hospitals Ready for the Coming Wave of Corona Cases?

The German health-care system is considered one of the best in the world. But the coronavirus is mercilessly exposing its weaknesses, with some hospitals already facing difficulties. Can Germany prevent the kind of collapse seen in Italy?

The Global Race to Develop a Coronavirus Vaccine - AFP

"A Very Aggressive Timeline" The Global Race to Develop a Coronavirus Vaccine

The first human trials for a new coronavirus vaccine have already started as myriad laboratories are pursuing a number of different strategies to stop the disease. But initial results aren't expected for several months. By Veronika Hackenbroch, Kerstin Kullmann, Martin Schlak und Thomas Schulz

"Saturday Is a Crucial Day" - Peter Rigaud

Chancellor Merkel's Chief of Staff "Saturday Is a Crucial Day"

Helge Braun, 47, Chancellor Angela Merkel's chief of staff, speaks with DER SPIEGEL about the rapidly rising number of coronavirus infections and about whether more stringent measures will have to be implemented. Interview Conducted by Christoph Hickmann und Martin Knobbe

The Woman Who Can Smell Parkinson's - Daniel Etter/ DER SPIEGEL

Scent of Musk The Woman Who Can Smell Parkinson's

So far, no cure has been found for Parkinson's. It is only possible to treat the symptoms. But a nurse in Scotland can smell the disease before it is diagnosed, and researchers are hoping she can help on the search for a breakthrough. Von Timofey Neshitov und Daniel Etter

The Pressure to Be Beautiful in South Korea - Suhwa Lee/ SPIEGEL ONLINE

Plastic Surgery and Botox The Pressure to Be Beautiful in South Korea

Lips plumped up during the lunch break, implants for a rounder head: Cosmetic surgery is extremely common in South Korea, even among men. The pressure to look good in the country is immense. Von Katharina Graça Peters

New App from Berlin Making Headway in Healthcare - Ada Health

Dr. Smartphone New App from Berlin Making Headway in Healthcare

Patients are increasingly using software to try to self-diagnose their ailments. A new Berlin startup is seeking to turn your smartphone into your family doctor. Von Martin U. Müller

Medical Applications Expose Current Limits of AI - DPA

Playing Doctor with Watson Medical Applications Expose Current Limits of AI

IBM has big plans for how its Watson artificial intelligence software could change the medical industry. But a number of hospitals have ended their experiments with the platform, arguing that it doesn't help diagnose or treat diseases. Von Martin U. Müller

'It Was the First Time I Cried in the Operating Room' - Stephanie Mitchell / Harvard University

Separating Siamese Twins 'It Was the First Time I Cried in the Operating Room'

When pediatric surgeon Allan Goldstein entered the operating room to separate conjoined twins, he did so with the knowledge that one would have to die in order to save the other. He recalls the enormous surgical and ethical challenges.

'We're Reluctant to Talk About Death' - Sean Gallup/ Getty Images

End of Life Care 'We're Reluctant to Talk About Death'

Bestselling author Dr. Atul Gawande's new book focuses on medical care for the dying. In an interview, he speaks with SPIEGEL about end-of-life priorities, when treatment is a mistake and how rules in care homes are made to be broken. Von Laura Höflinger

Whistleblower on Medical Research Fraud 'Positive Results Are Better for Your Career'

In an interview, whistleblower Peter Wilmshurst discusses how pressure from Big Pharma corrupts research into new medicines and leads companies to cover up fraudulent data. He says he has no regrets about taking on an entire industry. Von Rafaela von Bredow und Veronika Hackenbroch

Europe Isn't The Center of Focus - FABRIZIO BENSCH/ REUTERS

Conflict 7 Europe Isn't The Center of Focus

An aim of IMI was to make the European pharmaceutical industry more competitive. But as the Combacte project shows, the real beneficiaries were often meant to be elsewhere.

IMI Rules Come With Hitches - A3390 Kay Nietfeld/ dpa

Conflict 6 IMI Rules Come With Hitches

IMI is hoping to bring together representatives of industry, small- and medium-sized businesses and academics -- but in doing so, it is alienating many universities in Europe. Mid-sized research institutes are also having a tough time.

Seite 1 / 4

Ältere Artikel

Die Wiedergabe wurde unterbrochen.

Merkliste

Speichern Sie Ihre Lieblingsartikel in der persönlichen Merkliste, um sie später zu lesen und einfach wiederzufinden.

Sie haben noch kein SPIEGEL-Konto? Jetzt registrieren

Mehrfachnutzung erkannt

Bitte beachten Sie: Die zeitgleiche Nutzung von SPIEGEL+-Inhalten ist auf ein Gerät beschränkt. Wir behalten uns vor, die Mehrfachnutzung zukünftig technisch zu unterbinden.

Sie möchten SPIEGEL+ auf mehreren Geräten zeitgleich nutzen? Zu unseren Angeboten